The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult
Open accessAbstract
Objective : To review effectiveness of screening for colorectal cancer with faecal occult blood test, Hemoccult, and to consider benefits and harms of screening. Design : Systematic review of trials of Hemoccult screening, with meta-analysis of results from the randomised controlled trials. Subjects : Four randomised controlled trials and two non-randomised trials of about 330 000 and 113 000 people respectively aged ≥ years in five countries. Main outcome measures : Meta-analysis of effects of screening on mortality from colorectal cancer. Results : Quality of trial design was generally high, and screening resulted in a favourable shift in the stage distribution of colorectal cancers in the screening groups. Meta-analysis of mortality results from the four randomised controlled trials showed that those allocated to screening had a reduction in mortality from colorectal cancer of 16% (relative risk 0.84 (95% confidence interval 0.77 to 0.93)). When adjusted for attendance for screening, this reduction was 23% (relative risk 0.77 (0.57 to 0.89)) for people actually screened. If a biennial Hemoccult screening programme were offered to 10 000 people and about two thirds attended for at least one Hemoccult test, 8.5 (3.6 to 13.5) deaths from colorectal cancer would be prevented over a period of 10 years. Conclusion : Although benefits of screening are likely to outweigh harms for populations at high risk of colorectal cancer, more information is needed about the harmful effects of screening, the community's responses to screening, and costs of screening for different healthcare systems before widespread screening can be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
Petitti, D. B. (1994) · Medical Entomology and Zoology · Cited by 869
A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening
Allison, J. E., Tekawa, I. S., Ransom, L. J., & Adrain, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340304 · Cited by 622
RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER
Hardcastle, J. D., Chamberlain, J., Sheffield, J., Balfour, T. W., Armitage, N. C., Thomas, W. M., Pye, G., James, P. D., Amar, S. S., & Moss, S. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92750-5 · Cited by 529
An evidence based approach to individualising treatment
Glasziou, P. P., & Irwig, L. M. (1995) · BMJ · doi:10.1136/bmj.311.7016.1356 · Cited by 391
Screening for Colorectal Cancer With Fecal Occult Blood Testing and Sigmoidoscopy
Winawer, S. J., Flehinger, B. J., Schottenfeld, D., & Miller, D. G. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.16.1311 · Cited by 381
Cancer Risk in Relatives of Patients with Common Colorectal Cancer
St. John, D. J. B., McDermott, F. T., Hopper, J. L., Debney, E. A., Johnson, W. R., & Hughes, E. S. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00005 · Cited by 368
Kewenter, J., Brevinge, H., Engarás, B., Haglind, E., & Ährén, C. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409096840 · Cited by 249
Stewart-Brown, S., & Farmer, A. (1997) · BMJ · doi:10.1136/bmj.314.7080.533 · Cited by 188
Kronborg, O., Fenger, C., Olsen, J. H., Bech, K., & Søndergaard, O. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909093096 · Cited by 149
Muscholl, M. W., Hense, H., Bröckel, U., Döring, A., Riegger, G. A. J., & Schunkert, H. (1998) · BMJ · doi:10.1136/bmj.317.7158.565 · Cited by 88
Castiglione, G., Zappa, M., Grazzini, G., Mazzotta, A., Biagini, M., Salvadori, P. A., & Ciatto, S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.329 · Cited by 84
Participation in mass screening for colorectal cancer
Fuivrr, J., Arwux, P., Milm, C., et al. (1991) · European Journal of Cancer Prevention · doi:10.1097/00008469-199110000-00010 · Cited by 63
Endoscopic and surgical complications of work-up in screening for colorectal cancer
Kewenter, J., & Brevinge, H. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02056949 · Cited by 63
Meta-analysis adjusting for compliance: The example of screening for breast cancer
Glasziou, P. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90166-k · Cited by 60
Research works printed but not linked: 7
- Mulrow CD Oxman AD , eds. Critical appraisal ofs tudies. Cochrane Collaboration handbook [updated 9 December 1996]. Section 6. In: The Cochrane Library [database on disc and CD ROM]. Cochrane Collaboration; Issue 1.Oxford:Update Software; 1997. Updated quarterly.
- Petitti DB .Meta-analysis, decision analysis andc ost-effectiveness analysis: methods for quantitative synthesis inm edicine. Oxford:Oxford University Press,1994.
- 10.1016/0021-9681(80)90034-X · doi:10.1016/0021-9681(80)90034-x
- 10.1002/1097-0142(19880801)62:3<645::AID-CNCR2820620333>3.0.CO;2-# · doi:10.1002/1097-0142(19880801)62:3<645::aid-cncr2820620333>3.0.co;2-#
- Church TR Mandel JS Bond JH Ederer F Snover DC Bradley GM .Colon cancer control study: status and current issues. In: Miller AB Chamberlain J Day NE Hakama M Prorok PD , eds. Cancers creening. Cambridge:Cambridge University Press,1991:83–105.
- 10.1002/1097-0142(19850701)56:1<95::AID-CNCR2820560116>3.0.CO;2-K · doi:10.1002/1097-0142(19850701)56:1<95::aid-cncr2820560116>3.0.co;2-k
- Dunlop, 1992, Screening for large bowel cancer ini ndividuals with a family history of colorectal cancer., Br J Surg, 79, 488, 10.1002/bjs.1800790606 · doi:10.1002/bjs.1800790606
Cited by
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,351
Association of Colonoscopy and Death From Colorectal Cancer
Baxter, N. N., Goldwasser, M. A., Paszat, L. F., Saskin, R., Urbach, D. R., & Rabeneck, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00306 · Cited by 1,254
Metadata
- Authors
- Bernie, T., Les, I., Paul, G., Jan, K., David, W., & Chris, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1998-08-29
- Volume
- 317
- Issue
- 7158
- Pages
- 559-565
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2009460002
- Cited by
- 811
- References
- 19
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.